Literature DB >> 29095419

Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.

Andrea Bollom1, Jasmine Austrie, William Hirsch, Judy Nee, Daniel Friedlander, Johanna Iturrino, Sarah Ballou, Anthony Lembo.   

Abstract

BACKGROUND AND AIMS: Chronic cannabis use is associated with nausea and vomiting that may lead to emergency department (ED) visits, multiple diagnostic tests, and procedures. The aim of this study was to analyze recent trends in ED visits for vomiting associated with cannabis use disorder between 2006 and 2013.
METHODS: Data were obtained from the National Emergency Department Sample records in which vomiting (ICD-9-CM codes 787.01, 787.03, and 536.2) was a primary diagnosis in combination with cannabis abuse or dependence (304.3, 304.30, 304.31, 304.32, 304.33, 305.2, 305.20, 305.21, 305.22, and 305.23) and were seen in the ED between 2006 and 2013. The National Emergency Department Sample collects data from more than 25 million visits in over 950 EDs and is weighted to provide national estimates.
RESULTS: The rate of ED visits for vomiting with cannabis use disorder from 2006 compared with 2013 increased from 2.3 to 13.3 per 100,000 ED visits, while the mean inflation-adjusted costs increased 68.5% from $2758.43 to $4647.62, respectively. Men between the ages of 20 and 29 were the most common group to present to the ED for vomiting with cannabis use disorder. The Midwest and West had the higher rates of ED visits for vomiting with cannabis use disorder compared with the Northeast and South.
CONCLUSIONS: ED visits for vomiting associated with cannabis use disorder is common and is associated with significant medical costs. Further research on the role of cannabis use in nausea and vomiting is warranted.

Entities:  

Mesh:

Year:  2018        PMID: 29095419      PMCID: PMC5930153          DOI: 10.1097/MCG.0000000000000944

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  32 in total

1.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 2.  A review of the world cannabis situation.

Authors:  T Leggett
Journal:  Bull Narc       Date:  2006

3.  Sixty seconds on . . . medical marijuana.

Authors:  Anne Gulland
Journal:  BMJ       Date:  2016-07-19

Review 4.  Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.

Authors:  Kevin P Hill
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

Review 5.  The role of cannabinoids in regulation of nausea and vomiting, and visceral pain.

Authors:  Zubair Malik; Daniel Baik; Ron Schey
Journal:  Curr Gastroenterol Rep       Date:  2015-02

Review 6.  Medical marijuana for cancer.

Authors:  Joan L Kramer
Journal:  CA Cancer J Clin       Date:  2014-12-10       Impact factor: 508.702

Review 7.  The pharmacologic and clinical effects of medical cannabis.

Authors:  Laura M Borgelt; Kari L Franson; Abraham M Nussbaum; George S Wang
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

8.  Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2015-09-18       Impact factor: 4.530

9.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

10.  Cannabinoid hyperemesis syndrome.

Authors:  Shusen Sun; Anthony E Zimmermann
Journal:  Hosp Pharm       Date:  2013-09
View more
  6 in total

Review 1.  Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings.

Authors:  Deborah S Hasin; Dvora Shmulewitz; Aaron L Sarvet
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-14       Impact factor: 3.829

2.  Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws.

Authors:  Deborah S Hasin; Jacob Borodovsky; Dvora Shmulewitz; Claire Walsh; Ofir Livne; Cara A Struble; Efrat Aharonovich; David S Fink; Alan Budney
Journal:  Drug Alcohol Depend       Date:  2021-10-29       Impact factor: 4.492

3.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.

Authors:  Thangam Venkatesan; David J Levinthal; B U K Li; Sally E Tarbell; Kathleen A Adams; Robert M Issenman; Irene Sarosiek; Safwan S Jaradeh; Ravi N Sharaf; Shahnaz Sultan; Christopher D Stave; Andrew A Monte; William L Hasler
Journal:  Neurogastroenterol Motil       Date:  2019-06       Impact factor: 3.598

Review 4.  The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review.

Authors:  Kevin M Takakuwa; Raquel M Schears
Journal:  Int J Emerg Med       Date:  2021-02-10

5.  Beliefs about marijuana use during pregnancy and breastfeeding held by residents of a Latino-majority, rural region of California.

Authors:  Linda D Cameron; Sara E Fleszar-Pavlović; Marisela Yepez; Rosa D Manzo; Paul M Brown
Journal:  J Behav Med       Date:  2022-04-04

Review 6.  Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department.

Authors:  Mohammad Razban; Aristomenis K Exadaktylos; Vincent Della Santa; Eric P Heymann
Journal:  Int J Emerg Med       Date:  2022-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.